201 related articles for article (PubMed ID: 35841004)
1. Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis.
Kim Y; Nam Y; Rim YA; Ju JH
Stem Cell Res Ther; 2022 Jul; 13(1):303. PubMed ID: 35841004
[TBL] [Abstract][Full Text] [Related]
2. Establishment and gene expression analysis of disease-derived induced pluripotent stem cells of scleroderma.
Wang Z; Nakamura K; Jinnin M; Kudo H; Goto M; Era T; Kira T; Nakashima T; Fukushima S; Ihn H
J Dermatol Sci; 2016 Nov; 84(2):186-196. PubMed ID: 27510999
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Disabled-2 on skin fibrosis in systemic sclerosis.
Mei X; Zhao H; Huang Y; Tang Y; Shi X; Pu W; Jiang S; Ma Y; Zhang Y; Bai L; Tu W; Zhao Y; Jin L; Wu W; Wang J; Liu Q
J Dermatol Sci; 2020 Jul; 99(1):44-52. PubMed ID: 32571632
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a complex skin structure via layered co-culture of keratinocytes and fibroblasts derived from induced pluripotent stem cells.
Kim Y; Park N; Rim YA; Nam Y; Jung H; Lee K; Ju JH
Stem Cell Res Ther; 2018 Aug; 9(1):217. PubMed ID: 30103800
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory Regulation of Skin Fibrosis in Systemic Sclerosis by Apelin/APJ Signaling.
Yokoyama Y; Sekiguchi A; Fujiwara C; Uchiyama A; Uehara A; Ogino S; Torii R; Ishikawa O; Motegi SI
Arthritis Rheumatol; 2018 Oct; 70(10):1661-1672. PubMed ID: 29676521
[TBL] [Abstract][Full Text] [Related]
6. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
Carvalheiro T; Malvar Fernández B; Ottria A; Giovannone B; Marut W; Reedquist KA; Garcia S; Radstake TR
Rheumatology (Oxford); 2020 Sep; 59(9):2258-2263. PubMed ID: 31840182
[TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
[TBL] [Abstract][Full Text] [Related]
8. CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
Shimada S; Makino K; Jinnin M; Sawamura S; Kawano Y; Ide M; Kajihara I; Makino T; Fukushima S; Ihn H
J Dermatol Sci; 2020 Dec; 100(3):183-191. PubMed ID: 33055012
[TBL] [Abstract][Full Text] [Related]
9. Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts.
Brown M; Postlethwaite AE; Myers LK; Hasty KA
Clin Rheumatol; 2012 Jun; 31(6):973-81. PubMed ID: 22367096
[TBL] [Abstract][Full Text] [Related]
10. Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.
Wu M; Pedroza M; Lafyatis R; George AT; Mayes MD; Assassi S; Tan FK; Brenner MB; Agarwal SK
Arthritis Rheumatol; 2014 Apr; 66(4):1010-21. PubMed ID: 24757152
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
[TBL] [Abstract][Full Text] [Related]
12. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.
Huang J; Beyer C; Palumbo-Zerr K; Zhang Y; Ramming A; Distler A; Gelse K; Distler O; Schett G; Wollin L; Distler JH
Ann Rheum Dis; 2016 May; 75(5):883-90. PubMed ID: 25858641
[TBL] [Abstract][Full Text] [Related]
13. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
[TBL] [Abstract][Full Text] [Related]
14. A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.
Taroni JN; Greene CS; Martyanov V; Wood TA; Christmann RB; Farber HW; Lafyatis RA; Denton CP; Hinchcliff ME; Pioli PA; Mahoney JM; Whitfield ML
Genome Med; 2017 Mar; 9(1):27. PubMed ID: 28330499
[TBL] [Abstract][Full Text] [Related]
15. The involvement of leucine-rich α-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model.
Nakajima H; Nakajima K; Serada S; Fujimoto M; Naka T; Sano S
Mod Rheumatol; 2021 Nov; 31(6):1120-1128. PubMed ID: 33535851
[TBL] [Abstract][Full Text] [Related]
16. Antifibrotic effects and mechanisms of mesenchymal stem cell-derived exosomes in a systemic sclerosis mouse model: Possible contribution of miR-196b-5p.
Baral H; Uchiyama A; Yokoyama Y; Sekiguchi A; Yamazaki S; Amalia SN; Inoue Y; Ogino S; Torii R; Hosoi M; Matsuzaki T; Motegi SI
J Dermatol Sci; 2021 Oct; 104(1):39-47. PubMed ID: 34479773
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis reveals key genes modulated by ALK5 inhibition in a bleomycin model of systemic sclerosis.
Decato BE; Ammar R; Reinke-Breen L; Thompson JR; Azzara AV
Rheumatology (Oxford); 2022 Apr; 61(4):1717-1727. PubMed ID: 34289031
[TBL] [Abstract][Full Text] [Related]
18. Salvianolic acid B attenuates experimental skin fibrosis of systemic sclerosis.
Liu Q; Lu J; Lin J; Tang Y; Pu W; Shi X; Jiang S; Liu J; Ma Y; Li Y; Xu J; Jin L; Wang J; Wu W
Biomed Pharmacother; 2019 Feb; 110():546-553. PubMed ID: 30530290
[TBL] [Abstract][Full Text] [Related]
19. The Regulation of Skin Fibrosis in Systemic Sclerosis by Extracellular ATP via P2Y
Perera LMB; Sekiguchi A; Uchiyama A; Uehara A; Fujiwara C; Yamazaki S; Yokoyama Y; Ogino S; Torii R; Hosoi M; Ishikawa O; Motegi SI
J Invest Dermatol; 2019 Apr; 139(4):890-899. PubMed ID: 30404019
[TBL] [Abstract][Full Text] [Related]
20. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]